epirubicin hydrochloride
PolandDrugs containing this active substance
-
The medicine is used in the treatment of breast cancer, advanced ovarian cancer, stomach cancer, small cell lung cancer, and superficial or very localized bladder cancer.
Form: solution for injection
Active substance Dosage epirubicin hydrochloride 2 mg/ml ATC: L01DB03
Manufacturer: medac GmbH for Clinical Special Preparations
-
The medicine is used to treat various cancers, such as breast, lung, ovarian, and stomach cancer. It may be administered alone or in combination with other medicines, and in the case of bladder wall cancers, it may be administered directly into the bladder.
Form: solution for injection for infusion
Active substance Dosage epirubicin hydrochloride 2 mg/ml ATC: L01DB03
Manufacturer: Accord Healthcare Polska Sp. z o.o.
-
The medicinal product is used to treat many types of cancer, such as breast, ovarian, stomach, lung, head and neck, colon and rectal cancer, as well as in the treatment of multiple myeloma, non-Hodgkin lymphomas, acute leukemias, and certain bladder cancers.
Form: solution for infusion, concentrate
Active substance Dosage epirubicin hydrochloride 2 mg/ml ATC: L01DB03
Manufacturer: Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH
-
The medicinal product is used in the treatment of various types of cancer, including breast cancer, bladder cancer, stomach cancer, lung cancer, ovarian cancer, pancreatic cancer, colon and rectal cancer, lymphomas, leukemias, multiple myeloma, and soft tissue sarcomas.
Form: solution for injection and infusion
Active substance Dosage epirubicin hydrochloride 50 mg ATC: L01DB03
Manufacturer: Pfizer Service Company BV